Board of Directors
Experienced leaders providing strategic guidance and corporate oversight to fuel our growth.
Meet the Board →Built by Scientists. Driven by Discovery.
IROA Technologies provides the scientific measurement infrastructure that enables high-confidence biological research.
Our Story
Every Innovation Begins with a Challenge
Metabolomics promised to transform biological research, but inconsistent measurements and complex analytical workflows limited its full potential.
Founded in 2010 in Ann Arbor, Michigan, IROA Technologies was created to solve these challenges. We develop integrated scientific infrastructure that improves the accuracy, reproducibility, and confidence of biological measurements by combining stable isotope chemistry, reference standards, software, quality control, workflow standardization, and data analytics into unified platforms that accelerate scientific discovery.
Purpose
We founded IROA to establish the global standard for scientific measurement confidence, enabling researchers, clinicians, and innovators to make high-confidence biological decisions through reproducible, quantitative, and standardized analytical science.
Technology
Integrated software, authentic libraries, and isotope-based internal standards working together in one seamless workflow to increase confidence in biological measurements.
Expertise
Built on decades of scientific leadership IROA advances the science of metabolomics through innovation, education, collaboration, and publication.
Impact
Every measurement. Every experiment. Every decision. More confident.
Our Journey
Milestones That Shape Our Future
Since our founding in 2010, every milestone has strengthened our mission to solving the world's most difficult analytical measurement challenges.
2010
IROA Technologies was founded in Ann Arbor, Michigan with a mission to transform complex analytical measurements into reliable biological knowledge that accelerates research, innovation, and human health.
2012
Introduced isotope-based internal standards and ClusterFinder algorithms to lay the foundation for reproducible metabolomics measurements.
2014
Expanded our portfolio with authentic metabolite libraries, enabling more confident compound identification.
2015
Advanced our software ecosystem to extract noise-free IROA data ready for statistical analysis and visualization.
2020-2025
Development of automated complex Workflow sample sets, real-time library building, verifiable peak identification, suppression correction and normalization.
Today
Supporting scientists worldwide with integrated technologies that improve measurement confidence through stable isotope chemistry, workflow standardization, quality assurance, computational analytics, and scientific expertise.
OUR FOUNDERS
Decades of Experience. One Shared Purpose.
Our founders bring a lifelong commitment to science, innovation and building solutions that transform metabolomics research.
Chris Beecher
Founder & Chief Scientific OfficerA pioneer in metabolomics with more than 25 years of experience in drug discovery and development, 15 patents and 100+ publications.
- Former Director, Metabolon, Inc.
- Founding Director, UM Metabolomics Center
- Former Associate Professor, University of Illinois at Chicago
- Former Director, Paradigm Genetics
- Former Associate Director, University of Florida SECIM Center
Felice A. de Jong
Founder & Chief Executive OfficerA leader in life science and metabolomics with a proven track record in building innovative scientific solutions and organizations.
- Former President, Sigma Aldrich Australia
- Former President, RBi (Sigma-Aldrich)
- Former Director of Business Development, Metabolon
- Creator of MSMLS library and IROA internal standards
LEADERSHIP & ADVISORS
Guided by Leaders. Strengthened by Science.
Our leadership and advisory boards consist of globally recognized experts who provide strategic oversight and scientific guidance, ensuring continuous innovation and excellence in metabolomics research and technology development.
Scientific Advisory Board
World-class scientists advising on innovation, quality and the future of metabolomics.
Meet Our Advisors →